Manulife (Manufacturers Life Insurance)
ZYNE

Manulife (Manufacturers Life Insurance)’s Zynerba Pharmaceuticals, Inc ZYNE Stock Holding History

Manulife (Manufacturers Life Insurance)’s Portfolio ZYNE Stock Details ZYNE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-16,368
Closed -$63K – 2958
2020
Q1 		$63K Buy
16,368
+1,745
+12% +$8.11K ﹤0.01% 2690
2019
Q4 		$88K Buy
14,623
+427
+3% +$2.92K ﹤0.01% 2816
2019
Q3 		$110K Buy
14,196
+435
+3% +$4.9K ﹤0.01% 2808
2019
Q2 		$186K Buy
+13,761
New +$159K ﹤0.01% 2687
2018
Q3 		– Sell
-590
Closed -$6K – 3993
2018
Q2 		$6K Sell
590
-3,693
-86% -$37.9K ﹤0.01% 4048
2018
Q1 		$37K Sell
4,283
-3,030
-41% -$32.7K ﹤0.01% 3625
2017
Q4 		$92K Buy
7,313
+6,810
+1,354% +$78.1K ﹤0.01% 3417
2017
Q3 		$4K Sell
503
-8,853
-95% -$93.6K ﹤0.01% 4061
2017
Q2 		$158K Buy
+9,356
New +$186K ﹤0.01% 3195
2016
Q2 		– Sell
-891
Closed -$8K – 4360
2016
Q1 		$8K Buy
+891
New +$7.19K ﹤0.01% 3688

Other funds holding ZYNE

EMG
ETF Managers Group Summit, New Jersey $3.1B AUM 17.12% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
ZCA
Zeke Capital Advisors Berwyn, Pennsylvania $1.53B AUM 17.37% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PCM
Prentice Capital Management Greenwich, Connecticut $45.7M AUM 2.65% 1-Year Est. Return
AI
AdvisorShares Investments Bethesda, Maryland $828M AUM 37.72% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 57.61% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Manulife (Manufacturers Life Insurance)'s ZYNE Position: Q2 2020 in Review

Manulife (Manufacturers Life Insurance) sold out of Zynerba Pharmaceuticals, Inc (ZYNE) in Q2 2020, closing a stake of 16,368 shares — an estimated $63K sold.

Manulife (Manufacturers Life Insurance) first reported a position in ZYNE in Q1 2016 and held it in 10 quarters. The position peaked at $186K in Q2 2019. 74 funds tracked by Wall St. Rank hold ZYNE as of Q2 2020.

  • Manulife (Manufacturers Life Insurance) reported no remaining Zynerba Pharmaceuticals, Inc position as of Q2 2020 after selling out during the quarter.
  • Manulife (Manufacturers Life Insurance) sold 16,368 Zynerba Pharmaceuticals, Inc shares in Q2 2020, an estimated $63K.
  • Manulife (Manufacturers Life Insurance) first reported a position in Zynerba Pharmaceuticals, Inc in Q1 2016 and held it in 10 quarters.
  • Manulife (Manufacturers Life Insurance)'s Zynerba Pharmaceuticals, Inc position peaked at $186K in Q2 2019.
  • 74 funds tracked by Wall St. Rank held Zynerba Pharmaceuticals, Inc as of Q2 2020.

Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q2 2020, filed 10 Aug 2020.